ИЗУЧЕНИЕ СОСТАВА МИКРОБИОТЫ КИШЕЧНИКА И МАРКЕРОВ СИСТЕМНОГО ВОСПАЛЕНИЯ У БОЛЬНЫХ С ХРОНИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК ДОДИАЛИЗНЫХ СТАДИЙ (44-48)

Список литературы: 1. Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013; 83:1010– 6. 2. Ahmed MS, Abed M, Voelkl J, Lang F. Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate. BMCNephrol. 2013; 14:244. 3. Aron-Wisnewsky JA, Clement K. The gut micro biome, diet, and links to cardio metabolic and chronic disorders. Nat RevNephrol 2016; 12: 169–181. Doi: 10.1038/nrneph.2015 4. Barreto FC, Barreto DV, Liabeuf S, Meert N, Glorieux G, Temmar M, et al., European Uremic Toxin Work Group(EUTox). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.Clin J Am Soc Nephrol. 2009; 4:1551–8. 5. Cruz-Mora J, Martínez-Hernández NE, Martín delCampo-López F, Viramontes-Hörner D, VizmanosLamotte B, Mu˜noz-Valle JF, et al. Effects of a symbiotic on gutmicrobiota in Mexican patients with end-stage renal disease. J Ren Nutr. 2014;24:330–5. 6. Dou L, Sallée M, Cerini C, Poitevin S, Gondouin B,Jourde-Chiche N, et al. The cardiovascular effect of the uremic solute indole-3 acetic acid. J Am Soc Nephrol.2015; 26:876–87. 7. Evenepoel P, Meijers BK, Bammens BR, Verbeke K. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl. 2009:S12– 9.45. Jourde-Chiche N, Dou L, Cerini C, Dignat- George F, 8. Guldris SC, Parra EG, Amenos AC. Gut micro biota in chronic kidney disease. Nefrología 2017; 37 (1- 2): 9–19 Doi: 10.1016/j. nefro.2016.05.008 9. Hevia A, Delgado S, Sánchez B, Margolles A. Molecular players involved in the interaction between beneficial bacteria and the immune system. Front Microbiol.2015; 6:1285.24. 10. Jemberg C, Löfmark S, Edlund C, Jansson JK. Long-term impact of antibiotic exposure on the human intestinal micro biota. Microbiology. 2010; 156:3216– 23. 11. Kaysen GA, Johansen KL, Chertow GM, Dalrymple LS, KornakJ, Grimes B, et al. Associations of trim ethylamine N-oxide with nutritional and inflammatory biomarkers and cardiovascular outcomes in patients new to dialysis. J RenNutr. 2015; 25:351–6. 12. Koppe L, Fouque D, Soulage CO. The Role of Gut Micro biota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease. Toxins (Basel) 2018; 10(4):155. Doi:10.3390/toxins10040155 13. Ogawa T, Shimada M, Nagano N, Ito K, Ando T, Shimomura Y, et al. Oral administration of bifid bacterium longum in agastro-resistant seamless capsule decreases serum phosphate levels in patients receiving hemodialysis. Clin Kidney J. 2012; 5:373–4. 14. Pavan M. Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease. Minerva Urol Nephrol. 2014 15. Vaziri ND, Liu SM, Lau WL, Khazaeli M, Nazertehrani S, Farzaneh SH, et al. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLOS ONE. 2014; 9:e114881. 16. Vaziri ND. Effect of Symbiotic Therapy on Gut-Derived Uremic Toxins and the Intestinal Micro biome in Patients with CKD. Clin J Am Soc Nephrol 2016; 11(2): 199–201. Doi: 10.2215/CJN.13631215 17. Vanholder R, de Smet R, Glorieux G, Argilés A, BaurmeisterU, Brunet P, et al., European Uremic Toxin Work Group(EUTox). Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int.2003; 63:1934–43 18. Viramontes-Hörner D, Márquez-Sandoval F, Martín-del-Campo F, Vizmanos-Lamotte B, SandovalRodríguez A, Armendáriz-Borunda J, et al. Effect ofa symbiotic gel (Lactobacillus acidophilus + Bifid bacterium lactis + Inulin) on presence and severity of gastrointestinal symptoms in hemodialysis patients. J Ren Nutr.2015; 25:284–91.